Caught a glimpse of the usual funny business around quittin time when someone scored a nice 50k ( I believe) purchase at .1026cts. - even when no one was offering at that price, and then immediately another purchase for 5k/10k at .11cts to end the day. But this nonsense is pretty inconsequential given what the future could hold.
My feeling is to many are focused on short term sales, filters in inventory/production, whether we attend this conference or that ( and by the way, they'd be irresponsible if they didn't attend the ISICEM in March) and think you just need to consistently reassure yourself that the product works and be patient for results of current dosing studies. I believe any/all relevant investors, partners & distributors are doing the same, and as continuing anecdotal and formal study results leak ( pour) out, their will be a groundswell of consensus among hospitals & physicians that they must have/use the filter-
As DC mentioned in recent shareholder letter, they're learning on the fly. Its gonna take time to nail down the best practice and myriad of applications. He's dropped hints along the way. When the CEO shares anecdotal stories of astonishing patient recovery from H1N1 induced infection, acute pancreatitis and severe E-coli, then thats a clue that we're on to something potentially "revolutionary" as he himself likes to paint it-
Granted it doesn't work every time. But as dr_red57dry said in a long ago post, these are sadly the very, very sick- the possibly already dead. I have no metric for valuation, no crystal ball for predictive share price. But c'mon folks, this is .10cts for what may eventually turn out to be a monster return and life saver for patients-
Sit back, be patient, let them go through the necessary trials & tests to determine use(s) - Possibly big news at ISICEM & year end 10-K in March -